Skip to main content
Equibles

MORGAN STANLEY

Position in NERV — Minerva Neurosciences, Inc.

CIK 895421 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$69,057
-$77,543 QoQ
Shares Held
12,443
-48.9% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NERV ranks #364 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NERV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $69,057 12,443
2026-03-31 $146,600 24,332
2025-12-31 $44,440 11,055
2025-09-30 $23,171 11,008
2025-06-30 $18,933 11,008
2025-03-31 $18,705 11,004
2024-12-31 $35,782 16,104
2024-09-30 $28,694 10,747
2024-06-30 $34,282 10,747
2024-03-31 $27,726 10,747
2023-12-31 $38,658 6,286
2023-09-30 $93,874 13,605
2023-06-30 $82,213 8,995
2023-03-31 $13,719 8,575
2022-12-31 $13,793 8,675
2022-09-30 $125,702 13,619
2022-06-30 $23,143 6,992
2022-03-31 $46,298 55,781
2021-12-31 $210,165 262,380
2021-09-30 $471,594 271,033
2021-06-30 $1,468,857 633,129
2021-03-31 $2,713,193 929,176
2020-12-31 $1,130,982 483,326
2020-09-30 $18,853 5,929
2020-06-30 $47,420 13,136
2020-03-31 $40,357 6,704